Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Chemokine IL-8 receptor antagonists claimed by GSK scientists

Nov. 8, 2001

Positive phase IV results reported for Olux in mild to moderate body psoriasis

Nov. 8, 2001

Positive preliminary data obtained for frozen OrCel in Rx of venous leg ulcers

Nov. 8, 2001

New chemokine IL-8 receptor antagonists under study at GSK

Nov. 2, 2001

Tissue engineering product to begin clinical trials in the U.S.

Oct. 26, 2001

Zindaclin receives approval in U.K. as acne treatment

Oct. 25, 2001

Companies form distribution agreement for new dermis allograft to treat incontinence

Oct. 24, 2001

Aptheal receives approval in U.K. for treatment of aphthous ulcers

Oct. 24, 2001

EADV news: alefacept provides sustained remission without rebound in psoriasis

Oct. 24, 2001

AstraZeneca patents new chemokine receptor modulators for psoriasis, COPD

Oct. 23, 2001

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...